Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KRAS | P01116 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | STAT3 | P40763 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | SCD | O00767 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16102509 | 0.86 | KRAS (0.61) | KRASGAAMAPTRAB9AMAPK1 | |
| SCHEMBL16122492 | 0.85 | KRAS (0.42) | KRASGAARAB9AALDH1A1 | |
| SCHEMBL16098893 | 0.83 | MEN1 (0.43) | KRASGAASMN1; SMN2 | |
| SCHEMBL16122845 | 0.78 | KRAS (0.77) | KRASGAA | |
| SCHEMBL16122494 | 0.78 | ALDH1A1 (0.36) | MAPTTSHREGLN1ALDH1A1 | |
| SCHEMBL16122663 | 0.77 | KRAS (0.58) | KRAS | |
| SCHEMBL16122797 | 0.76 | KRAS (0.67) | KRASGAA | |
| SCHEMBL16122363 | 0.75 | KRAS (0.61) | KRASGAARAB9ASCD | |
| SCHEMBL15337759 | 0.75 | KRAS (0.44) | KRASGAAEPHX2 | |
| SCHEMBL16093954 | 0.74 | KRAS (0.52) | KRASGAAMAPTMAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970121-A1 | COVALENT INHIBITORS OF KRAS G12C | Araxes Pharma LLC (US) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014152588-A1 | COVALENT INHIBITORS OF KRAS G12C | ARAXES PHARMA LLC (US) | 2014-09-25 | — | — | WO | disclosed |